journal article·2010-06-22

Nanostructured Assemblies for Dental Application

Florence Fioretti, Carlos Mendoza-Palomares, Marie Helms, Denise Al Alam, Ludovic Richert, Youri Arntz, Simon Rinckenbach, Fabien Garnier, Youssef Haïkel, Sophie C. Gangloff, Nadia Benkirane-Jessel

ACS Nano· Volume 4· Issue 6
Publisher page

Abstract

Millions of teeth are saved each year by root canal therapy. Although current treatment modalities offer high levels of success for many conditions, an ideal form of therapy might consist of regenerative approaches in which diseased or necrotic pulp tissues are removed and replaced with healthy pulp tissue to revitalize teeth. Melanocortin peptides (alpha-MSH) possess anti-inflammatory properties in many acute and chronic inflammatory models. Our recent studies have shown that alpha-MSH covalently coupled to poly-l-glutamic acid (PGA-alpha-MSH) retains anti-inflammatory properties on rat monocytes. This study aimed to define the effects of PGA-alpha-MSH on dental pulp fibroblasts. Lipopolysaccharide (LPS)-stimulated fibroblasts incubated with PGA-alpha-MSH showed an early time-dependent inhibition of TNF-alpha, a late induction of IL-10, and no effect on IL-8 secretion. However, in the absence of LPS, PGA-alpha-MSH induced IL-8 secretion and proliferation of pulp fibroblasts, whereas free alpha-MSH inhibited this proliferation. Thus, PGA-alpha-MSH has potential effects in promoting human pulp fibroblast adhesion and cell proliferation. It can also reduce the inflammatory state of LPS-stimulated pulp fibroblasts observed in gram-negative bacterial infections. These effects suggest a novel use of PGA-alpha-MSH as an anti-inflammatory agent in the treatment of endodontic lesions. To better understand these results, we have also used the multilayered polyelectrolyte films as a reservoir for PGA-alpha-MSH by using not only PLL (poly-l-lysine) but also the Dendri Graft poly-l-lysines (DGL(G4)) to be able to adsorb more PGA-alpha-MSH. Our results indicated clearly that, by using PGA-alpha-MSH, we increase not only the viability of cells but also the proliferation. We have also analyzed at the nanoscale by atomic force microscopy these nanostructured architectures and shown an increase of thickness and roughness in the presence of PGA-alpha-MSH incorporated into the multilayered film (PLL-PGA-alpha-MSH)(10) or (DGL(G4)-PGA-alpha-MSH)(10) in accordance with the increase of the proliferation of the cells growing on the surface of these architectures. We report here the first use of nanostructured and functionalized multilayered films containing alpha-MSH as a new active biomaterial for endodontic regeneration.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Polymer Surface Interaction Studies · Electrospun Nanofibers in Biomedical Applications · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 977, 11 rue Humann, Strasbourg, France

Faculté de Chirurgie Dentaire, Université de Strasbourg, UdS. Strasbourg, France

Laboratoire Immuno-Pharmacologie Cellulaire et Moléculaire, EA3796 UFR Pharmacie, URCA, 51, Rue Cognacq Jay, Reims, France

Centre National de la Recherche Scientifique (CNRS) UMR 7213, Faculté de Pharmacie de l’Université de Strasbourg (UdS), 74, route du Rhin, 67401 Illkirch Cedex, France

IBMM, UMR 5247, CNRS, Universite Montpellier 1&2, present address COLCOM, Cap Alpha, Avenue de l’ Europe,Clapiers, 34940 Montpellier Cedex 9, France

Hôpital Central, Service de Chirurgie Orthopédique and CNRS UMR 7561, 29, Av. du Maréchal de Lattre de Tassigny, 54035 Nancy Cedex, France

References (57)

Show source-provided references
1. Bashutski J. D. · J. Endod. · 2009 · 35 · 32110.1016/j.joen.2008.11.023 ↗
2. Böhm M. · J. Invest. Dermatol. · 2006 · 126 · 196610.1038/sj.jid.5700421 ↗
3. Boston B. A. · Ann. N.Y. Acad. Sci. · 1999 · 885 · 7510.1111/j.1749-6632.1999.tb08666.x ↗
4. Dumont L. M. · Peptides · 2005 · 26 · 192910.1016/j.peptides.2004.12.034 ↗
5. Catania A. · Trends Endocrinol. Metab. · 2000 · 11 · 30410.1016/S1043-2760(00)00296-4 ↗
6. Catania A. · Pharmacol. Rev. · 2004 · 56 · 110.1124/pr.56.1.1 ↗
7. Lam C. W. · Curr. Drug Targets · 2004 · 3 · 311
8. Kokot A. · Arthritis Rheum. · 2009 · 60 · 59210.1002/art.24228 ↗
9. Wikberg J. E. · Pharmacol. Res. · 2000 · 42 · 39310.1006/phrs.2000.0725 ↗
10. Gantz I. · Am. J. Physiol. Endocrinol. Metab. · 2003 · 284 · 46810.1152/ajpendo.00434.2002 ↗
11. Wong W. · Int. J. Biochem. Cell Biol. · 1996 · 28 · 122310.1016/S1357-2725(96)00074-X ↗
12. Getting S. J. · Pharmacol. Ther. · 2006 · 111 · 110.1016/j.pharmthera.2005.06.022 ↗
13. Sarkar A. · FEBS Lett. · 2003 · 553 · 28610.1016/S0014-5793(03)01029-9 ↗
14. Luger T. A. · Ann. N.Y. Acad. Sci. · 2003 · 994 · 13310.1111/j.1749-6632.2003.tb03172.x ↗
15. Ichiyama T. · J. Neurosci. Res. · 1999 · 58 · 68410.1002/(SICI)1097-4547(19991201)58:5<684::AID-JNR9>3.0.CO;2-# ↗
16. Ichiyama T. · J. Neuroimmunol. · 1999 · 99 · 21110.1016/S0165-5728(99)00122-8 ↗
17. Manna S. K. · J. Immunol. · 1998 · 161 · 287310.4049/jimmunol.161.6.2873 ↗
18. Hill R. · Peptides · 2006 · 27 · 42110.1016/j.peptides.2005.03.061 ↗
19. Bohm M. · J. Biol. Chem. · 2004 · 279 · 695910.1074/jbc.M312549200 ↗
20. Hill R. P. · Peptides · 2005 · 26 · 115010.1016/j.peptides.2005.01.019 ↗
21. Hedley S. J. · Pigm. Cell Res. · 2002 · 15 · 4910.1034/j.1600-0749.2002.00067.x ↗
22. Schiller M. · J. Biol. Chem. · 2009 · 26 · 1
23. Witherspoon D. E. · Pediatr. Dent. · 2008 · 30 · 220
24. Goldberg M. · Pharmacol. Res. · 2008 · 58 · 13710.1016/j.phrs.2008.05.013 ↗
25. Wisithphrom K. · J. Endod. · 2006 · 32 · 85310.1016/j.joen.2006.03.017 ↗
26. Chluba J. · Biomacromolecules · 2001 · 2 · 80010.1021/bm015529i ↗
27. Jessel N. · Adv. Mater. · 2004 · 16 · 150710.1002/adma.200306613 ↗
28. Jessel N. · Adv. Funct. Mater. · 2004 · 14 · 17410.1002/adfm.200304413 ↗
29. Schultz P. · Biomaterials · 2005 · 26 · 262110.1016/j.biomaterials.2004.06.049 ↗
30. Bohm M. · Ann. N.Y. Acad. Sci. · 1999 · 885 · 27710.1111/j.1749-6632.1999.tb08685.x ↗
31. Collet H. · Chem.—Eur. J. · 2010 · 16 · 230910.1002/chem.200901734 ↗
32. Collet H. · Tetrahedron Lett. · 1996 · 37 · 904310.1016/S0040-4039(96)01974-0 ↗
33. Commeyras A. · Polym. Int. · 2002 · 51 · 66110.1002/pi.1027 ↗
34. Jessel N. · Proc. Natl. Acad. Sci. U.S.A. · 2006 · 103 · 861810.1073/pnas.0508246103 ↗
35. Mason M. J. · J. Immunol. · 1989 · 142 · 164610.4049/jimmunol.142.5.1646 ↗
36. Colombo G. · Neuroimmunomodulation · 2002 · 10 · 20810.1159/000068323 ↗
37. Delgado R. · J. Leukocyte Biol. · 1998 · 63 · 74010.1002/jlb.63.6.740 ↗
38. Taherzadeh S. · Am. J. Physiol. · 1999 · 276 · 12810.1152/ajpcell.1999.276.1.C128 ↗
39. Getting S. J. · J. Immunol. · 1999 · 162 · 744610.4049/jimmunol.162.12.7446 ↗
40. Bohm M. · Exp Dermatol. · 2004 · 13 · 1610.1111/j.1600-0625.2004.00256.x ↗
41. Caruso F. · Science · 1998 · 282 · 11110.1126/science.282.5391.1111 ↗
42. Ho P. K. · Nature · 2000 · 404 · 48110.1038/35006610 ↗
43. Hiller J. · Nat. Mater. · 2002 · 1 · 5910.1038/nmat719 ↗
44. Tang Z. · Nat. Mater. · 2003 · 2 · 41310.1038/nmat906 ↗
45. Jessel N. · Adv. Mater. · 2003 · 15 · 69210.1002/adma.200304634 ↗
46. Jessel N. · Adv. Funct. Mater. · 2004 · 14 · 96310.1002/adfm.200305089 ↗
47. Jessel N. · Adv. Funct. Mater. · 2005 · 15 · 64810.1002/adfm.200400129 ↗
48. Picart C. · Adv. Funct. Mater. · 2005 · 15 · 177110.1002/adfm.200400588 ↗
49. Gangloff S. C. · Biomaterials · 2005 · 27 · 177110.1016/j.biomaterials.2005.10.001 ↗
50. Chu S. C. · J. Endod. · 2004 · 30 · 70410.1097/01.DON.0000129962.65752.C6 ↗
51. Min K. S. · J. Endod. · 2006 · 32 · 3910.1016/j.joen.2005.10.012 ↗
52. Tokuda M. · J. Endod. · 2002 · 28 · 17710.1097/00004770-200203000-00008 ↗
53. Silva A. C. · J. Appl. Oral Sci. · 2009 · 17 · 52710.1590/S1678-77572009000500031 ↗
54. Yamamoto M. · Nat. Immunol. · 2003 · 4 · 114410.1038/ni986 ↗
55. O’Neill L. A. · Trends Immunol. · 2004 · 25 · 68710.1016/j.it.2004.10.005 ↗
56. Getting S. J. · J. Pharmacol. Exp. Ther. · 2003 · 306 · 63110.1124/jpet.103.051623 ↗
57. Murray P. E. · J. Endod. · 2007 · 33 · 77